Human Embryonic Stem Cell Research and Unequal Access
Author Information
Author(s): Mark Moller
Primary Institution: Denison University
Hypothesis
Will unequal biological access arise in human embryonic stem cell research, disproportionately benefiting white Americans over minority ethnic groups?
Conclusion
The study highlights the risk of unequal access to therapies derived from human embryonic stem cell research, favoring white Americans unless corrective measures are taken.
Supporting Evidence
- White Americans are more likely to donate embryos for stem cell research, leading to a lack of diversity in stem cell lines.
- Ethnic minorities underutilize reproductive technologies, contributing to unequal access to stem cell therapies.
- Disparities in healthcare access and treatment outcomes exist for ethnic minorities in the U.S.
Takeaway
This paper talks about how some people might get better medical treatments from stem cell research just because of their race, and we need to fix that so everyone gets treated fairly.
Potential Biases
Potential bias in the representation of ethnic groups in stem cell research due to historical and systemic inequalities.
Limitations
The paper does not provide empirical data or specific case studies to support its claims.
Participant Demographics
Focuses on ethnic disparities in access to reproductive technologies and stem cell research.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website